Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001069530-22-000031
Filing Date
2022-06-10
Accepted
2022-06-10 17:22:05
Documents
5
Effectiveness Date
2022-06-10

Document Format Files

Seq Description Document Type Size
1 S-8 sava-20220610xs8.htm S-8 111417
2 EX-5.1 sava-20220610xex5_1.htm EX-5.1 19491
3 GRAPHIC sava-20220610xex5_1g001.jpg GRAPHIC 3455
4 EX-107 sava-20220610xex10.htm EX-FILING FEES 45531
5 EX-23.1 sava-20220610xex23_1.htm EX-23.1 2800
  Complete submission text file 0001069530-22-000031.txt   185284
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-265540 | Film No.: 221009937
SIC: 2834 Pharmaceutical Preparations